Heteromultivalent ligand-decoration for actively targeted nanomedicine

被引:35
作者
Modery-Pawlowski, Christa L. [1 ]
Sen Gupta, Anirban [1 ]
机构
[1] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA
关键词
Nanomedicine; Ligands; Receptors; Active targeting; Heteromultivalent; IN-VIVO; TRANSFERRIN RECEPTOR; ACTIVATED PLATELETS; ENDOTHELIAL-CELLS; DRUG-DELIVERY; P-SELECTIN; MULTIFUNCTIONAL NANOPARTICLES; ALPHA(V)BETA(3) INTEGRIN; PARTICLE-SHAPE; TUMOR-CELLS;
D O I
10.1016/j.biomaterials.2013.12.047
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Active targeting has become an important component of nanomedicine design where nanovehicles are surface-decorated with cell receptor-specific or disease matrix-specific ligands to enable site-selective binding, retention and delivery of theranostic cargo. In this context, there have been numerous reports regarding surface-modification of nanovehicles with antibodies, antibody fragments, carbohydrates, aptamers and peptides as targeting ligands. However, majority of these reports have focused on using a single type of targeting moiety on the vehicle surface. In any disease development and progression, multiple receptors and proteins are often spatio-temporally upregulated simultaneously and heterogeneously. Rationalizing from this, a significant advantage can be envisioned in targeting multiple entities simultaneously using vehicle co-decoration with multiple types of ligands, to enhance binding activity and targeting specificity. To this end, we present a comprehensive up-to-date review on research endeavors in heteromultivalent ligand-modification of nanovehicles and provide a mechanistic rationale as well as an insightful discussion of this promising area, including findings from our own research. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2568 / 2579
页数:12
相关论文
共 100 条
[1]   Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion [J].
Aceto, Nicola ;
Duss, Stephan ;
MacDonald, Gwen ;
Meyer, Dominique S. ;
Roloff, Tim-C ;
Hynes, Nancy E. ;
Bentires-Alj, Mohamed .
BREAST CANCER RESEARCH, 2012, 14 (05)
[2]   P-selectin in haemostasis [J].
André, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (03) :298-306
[3]   Efficient Delivery of Gold Nanoparticles by Dual Receptor Targeting [J].
Bhattacharyya, Sanjib ;
Khan, Jameel Ahmad ;
Curran, Geoffry L. ;
Robertson, J. David ;
Bhattacharya, Resham ;
Mukherjee, Priyabrata .
ADVANCED MATERIALS, 2011, 23 (43) :5034-5038
[4]   The adhesion molecule P-selectin and cardiovascular disease [J].
Blann, AD ;
Nadar, SK ;
Lip, GYH .
EUROPEAN HEART JOURNAL, 2003, 24 (24) :2166-2179
[5]   Adhesion of activated platelets to endothelial cells:: Evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), αvβ3 integrin, and GPIbα [J].
Bombeli, T ;
Schwartz, BR ;
Harlan, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (03) :329-339
[6]   Folate in head and neck squamous cell cancer chemoprevention: Purposely left out? [J].
Bossi, Paolo ;
Locati, Laura D. ;
Licitra, Lisa ;
Tagliabue, Elda .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) :3463-3463
[7]   Current status of nanotechnology approaches for cardiovascular disease: a personal perspective [J].
Buxton, Denis B. .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2009, 1 (02) :149-155
[8]   Active targeting schemes for nanoparticle systems in cancer therapeutics [J].
Byrne, James D. ;
Betancourt, Tania ;
Brannon-Peppas, Lisa .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (15) :1615-1626
[9]   Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers [J].
Caldorera-Moore, Mary ;
Guimard, Nathalie ;
Shi, Li ;
Roy, Krishnendu .
EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (04) :479-495
[10]   A new role in hemostasis for the adhesion receptor P-selectin [J].
Cambien, B ;
Wagner, DD .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (04) :179-186